about
Cimetidine-a clinical and pharmacokinetic study.Altered disposition and availability of cimetidine in liver cirrhotic patients.Pharmacokinetic studies of cimetidine and ranitidine before and after treatment in peptic ulcer patients.High concentrations of commonly used drugs can inhibit the in vitro glucuronidation of bisphenol A and nonylphenol in rats.Human variability in susceptibility to toxic chemicals--a preliminary analysis of pharmacokinetic data from normal volunteers.Intestinal permeability and its relevance for absorption and elimination.Conjunctive therapy of cisplatin with the OCT2 inhibitor cimetidine: influence on antitumor efficacy and systemic clearancePrediction of clearance and volume of distribution in the obese from normal weight subjects: an allometric approach.Forecasting oral absorption across biopharmaceutics classification system classes with physiologically based pharmacokinetic models.Prediction of Clearance and Volume of Distribution in the Obese from Normal Weight Subjects : An Allometric Approach.Cimetidine absorption in humans during sucralfate coadministration.The effect of metoclopramide and propantheline on the gastrointestinal absorption of cimetidine.Moxifloxacin Is a Potent In Vitro Inhibitor of OCT- and MATE-Mediated Transport of Metformin and Ethambutol.Comparative effects of famotidine and cimetidine on 7-ethoxycoumarin O-deethylase activity in human livers.Is the measurement of blood cimetidine levels useful?Elucidating the role of dose in the biopharmaceutics classification of drugs: the concepts of critical dose, effective in vivo solubility, and dose-dependent BCS.The influence of variable gastric emptying and intestinal transit rates on the plasma level curve of cimetidine; an explanation for the double peak phenomenon.
P2860
Q34448762-4EE95D02-2EF8-4A3D-92A1-1A3AC550231AQ34511816-246AE76C-0285-4AA0-8E56-4B2ABD66DBAEQ34620828-854C9B82-E5E2-4A6D-80EB-3ACF9E22821AQ35013124-D170FCD4-A55C-4210-868A-9548B733CE9EQ36457487-6C3C5FEB-C222-4A27-B018-1E8BFD070403Q36985043-F4D7E49F-3D73-4C0D-AC9F-17507F50635AQ37320350-7386F094-6BDC-4E1E-AA18-AC9356EA8056Q38016504-5637DAC4-2535-480C-9D7B-5B12A181F446Q38805505-F1F12335-67DE-4E6E-8C84-D1B3FC4B5B77Q38930369-D4955A85-304D-4B87-A468-794454718C05Q41852500-CC29D3C4-3717-4ECD-9B7A-A4EB504EE51FQ41997715-43C2E01E-21DE-4505-8B7D-C5D78D4DFD72Q42364862-3C9A433D-70D0-4DD3-9979-1A5004282E85Q43240614-B6ACE5D6-7F10-405E-8476-AF55415E6F92Q43241140-1D6E5A5F-1D6D-419D-B184-9E5431BE1EC8Q43786966-B8E057E5-DC9E-48BF-BB99-C393CCA82432Q51628265-12A9692C-39AC-4B38-904E-AA8D979CBAA5
P2860
description
1979 nî lūn-bûn
@nan
1979年の論文
@ja
1979年学术文章
@wuu
1979年学术文章
@zh
1979年学术文章
@zh-cn
1979年学术文章
@zh-hans
1979年学术文章
@zh-my
1979年学术文章
@zh-sg
1979年學術文章
@yue
1979年學術文章
@zh-hant
name
Bioavailability and pharmacokinetics of cimetidine.
@en
Bioavailability and pharmacokinetics of cimetidine.
@nl
type
label
Bioavailability and pharmacokinetics of cimetidine.
@en
Bioavailability and pharmacokinetics of cimetidine.
@nl
prefLabel
Bioavailability and pharmacokinetics of cimetidine.
@en
Bioavailability and pharmacokinetics of cimetidine.
@nl
P2093
P356
P1476
Bioavailability and pharmacokinetics of cimetidine.
@en
P2093
P2888
P304
P356
10.1007/BF00605632
P577
1979-11-01T00:00:00Z